Franziska Koch, Melanie Dietrich, Martina Green, Lutz Moikow, Mareike Schmidt, Matthias Ristig, Andreas Meier-Hellmann, Jörg-Peter Ritz
{"title":"[The Usefulness of ERAS Concepts for Colorectal Resections - an Economic Analysis under DRG Conditions].","authors":"Franziska Koch, Melanie Dietrich, Martina Green, Lutz Moikow, Mareike Schmidt, Matthias Ristig, Andreas Meier-Hellmann, Jörg-Peter Ritz","doi":"10.1055/a-1880-1309","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>ERAS (Enhanced Recovery After Surgery) describes a multimodal, interdisciplinary and interprofessional treatment concept that optimizes the postoperative convalescence of the patient through the use of evidence-based measures.</p><p><strong>Goal of the work: </strong>The aim of this article is to examine the economic feasibility of the concept in the German DRG system.</p><p><strong>Material and methods: </strong>Since August 2019, patients have been treated in our clinic according to the later certified ERAS concept. The last 20 patients before ERAS implementation are compared below with 20 patients after ERAS implementation, who were identified using a matched pair analysis. In addition to the comparison of costs and revenues, the clinical outcome of the patients is also presented.</p><p><strong>Results: </strong>The cases of the patients in the pre-ERAS cohort caused median costs of € 7432.83. BWR of 3.38 were billable. The resulting DRG revenue for the patients in this group amounted to € 11325.78. The proceeds generated in the end amounted to € 4575.14. The cases of patients in the ERAS cohort resulted in costs of € 5582.96. BWR of 2.84 could be billed. The DRG proceeds for the patients in this group therefore amounted to € 10014.18. The profit generated was thus € 4993.84.</p><p><strong>Discussion: </strong>The cost reduction generated by ERAS was comparable to the \"loss\" caused by the BWR decrease. ERAS is therefore also possible to cover costs in the German DRG system.</p>","PeriodicalId":23956,"journal":{"name":"Zentralblatt fur Chirurgie","volume":null,"pages":null},"PeriodicalIF":0.5000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zentralblatt fur Chirurgie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-1880-1309","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/9/5 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: ERAS (Enhanced Recovery After Surgery) describes a multimodal, interdisciplinary and interprofessional treatment concept that optimizes the postoperative convalescence of the patient through the use of evidence-based measures.
Goal of the work: The aim of this article is to examine the economic feasibility of the concept in the German DRG system.
Material and methods: Since August 2019, patients have been treated in our clinic according to the later certified ERAS concept. The last 20 patients before ERAS implementation are compared below with 20 patients after ERAS implementation, who were identified using a matched pair analysis. In addition to the comparison of costs and revenues, the clinical outcome of the patients is also presented.
Results: The cases of the patients in the pre-ERAS cohort caused median costs of € 7432.83. BWR of 3.38 were billable. The resulting DRG revenue for the patients in this group amounted to € 11325.78. The proceeds generated in the end amounted to € 4575.14. The cases of patients in the ERAS cohort resulted in costs of € 5582.96. BWR of 2.84 could be billed. The DRG proceeds for the patients in this group therefore amounted to € 10014.18. The profit generated was thus € 4993.84.
Discussion: The cost reduction generated by ERAS was comparable to the "loss" caused by the BWR decrease. ERAS is therefore also possible to cover costs in the German DRG system.
背景:ERAS(Enhanced Recovery After Surgery)描述了一种多模式、跨学科和跨专业的治疗概念,通过使用循证措施优化患者的术后恢复。工作目标:本文的目的是检验该概念在德国DRG系统中的经济可行性。材料和方法:自2019年8月以来,患者在我们的诊所按照后来认证的ERAS概念进行治疗。下面将实施ERAS前的最后20名患者与实施ERAS后的20名患者进行比较,这些患者是使用配对分析确定的。除了成本和收入的比较外,还介绍了患者的临床结果。结果:ERAS前队列患者的病例导致的中位费用为7432.83欧元。3.38的BWR是可计费的。该组患者的DRG收入达到11325.78欧元。最终产生的收益为4575.14欧元。ERAS队列中的患者病例导致5582.96欧元的费用。可以对2.84的BWR进行计费。因此,该组患者的DRG收益为10014.18欧元。因此产生的利润为4993.84欧元。讨论:ERAS产生的成本减少与BWR减少造成的“损失”相当。因此,ERAS也可以覆盖德国DRG系统中的成本。
期刊介绍:
Konzentriertes Fachwissen aus Forschung und Praxis
Das Zentralblatt für Chirurgie – alle Neuigkeiten aus der Allgemeinen, Viszeral-, Thorax- und Gefäßchirurgie.